Long School of Medicine

UT Health San Antonio creates innovative organoid for advancing understanding of pancreatic cancer 

<p>&nbsp; Pancreatic ductal adenocarcinoma (PDAC), a certain type of pancreatic cancer, is a ruthless killer with an average five-year survival rate of less than 10%. Most patients are diagnosed at a late stage when the cancer has already spread throughout their bodies. And the problem is only growing worse. By 2030, pancreatic cancer is expected [&hellip;]</p>

Share This Story